Revolution Medicines, Inc. (RVMD)
182.25
+4.29
(+2.41%)
USD |
NASDAQ |
Oct 19, 14:02
Revolution Medicines Cash from Operations (Annual) : -897.74M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -897.74M |
| December 31, 2024 | -557.44M |
| December 31, 2023 | -350.57M |
| December 31, 2022 | -224.40M |
| December 31, 2021 | -147.18M |
| Date | Value |
|---|---|
| December 31, 2020 | -100.06M |
| December 31, 2019 | -49.62M |
| December 31, 2018 | 1.213M |
| December 31, 2017 | -25.15M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Moderna, Inc. | -1.873B |
| Arrowhead Pharmaceuticals, Inc. | 179.55M |
| Intellia Therapeutics, Inc. | -394.74M |
| Oncolytics Biotech, Inc. | -20.11M |
| Twist Bioscience Corp. | -47.63M |